GlaxoSmithKline News and Research

RSS

HIV/AIDS groups express concern about potential for new antiretroviral advertising to 'scare off' patients

The Wall Street Journal on Monday examined a new trend for drugmakers marketing HIV/AIDS treatments to release ads that "tak[e] aim at rival HIV drugs, hinting at side effects and other drawbacks."

26 Aug 2008

AIDS Healthcare Foundation blasts GlaxoSmithKline print advertisements that promote fear of HIV treatment

AIDS Healthcare Foundation (AHF) is blasting British multi-national drug giant GlaxoSmithKline (GSK) for a recent series of direct-to-consumer print advertisements that, under the guise of patient education, capitalize on patients' fears of HIV treatment.

25 Aug 2008

Genmab announces four studies of ofatumumab in chronic lymphocytic leukemia

Genmab A/S announced today plans to begin four studies of ofatumumab in chronic lymphocytic leukemia (CLL) and follicular non-Hodgkin's lymphoma (NHL) this year.

25 Aug 2008

Infant deaths in clinical drug trials in India raise concern about ethical standards

The revelation that 49 babies died at a top Indian hospital during drug tests has shocked many and raised issues concerning ethical standards at the hospital.

25 Aug 2008

Warning issued on dangers of diabetes drug Avandia

Thousands of Australians who are taking the diabetes drug Avandia (rosiglitazone) have been urged by the drug's manufacturer to see their doctors following safety issues concerning the medication.

20 Aug 2008

GSK begins shipments of Fluarix and FluLaval to U.S. customers for 2008-2009 flu season

GlaxoSmithKline has announced that it will begin shipment of Flulaval [Influenza Virus Vaccine] and Fluarix [Influenza Virus Vaccine] to U.S. customers for the 2008-2009 influenza season.

11 Aug 2008

FDA approves seasons influenza vaccines

The U.S. Food and Drug Administration (FDA) today announced that it has approved this year's seasonal influenza vaccines that include new strains of the virus likely to cause flu in the United States during the 2008-2009 season.

5 Aug 2008

Abbott Labs agrees to settle lawsuit over antiretroviral Norvir pricing

Abbott Laboratories on Wednesday agreed to pay between $10 million and $27.5 million to settle an antitrust lawsuit filed by HIV/AIDS advocates and other drug companies over an increase in the price of the company's antiretroviral drug Norvir, the AP/International Herald Tribune reports (AP/International Herald Tribune, 7/31).

3 Aug 2008

UK's national HPV vaccination programme extended

The UK's national vaccination programme against HPV is being extended to offer protection to an additional 300,000 girls aged 17-18, starting in September, Public Health Minister Dawn Primarolo announced today.

21 Jul 2008

GlaxoSmithKline, Novartis found guilty of overcharging Alabama Medicaid Program

An Alabama state court jury on Tuesday found pharmaceutical companies GlaxoSmithKline and Novartis guilty of defrauding the state Medicaid program by charging artificially high prices for medications and ordered the two companies to pay more than $114 million in restitution, the AP/Minneapolis Star Tribune reports.

4 Jul 2008

Smoking ban triggered the biggest fall in smoking ever seen in England

Smokefree law in England has helped more smokers to quit than ever before and will help prevent an estimated 40,000 deaths over the next 10 years - according to new research being presented in Birmingham tomorrow (Tuesday).

30 Jun 2008

Treating genital herpes does not reduce eisk of HIV

Treating genital herpes does not reduce the risk of HIV, according to a study published on Friday in the journal Lancet, the AP/Newsweek reports (Cheng, AP/Newsweek, 6/19). Herpes simplex virus-2 has been shown to increase the risk of HIV by as much as threefold, so the researchers examined whether treating HSV-2 might reduce the risk of HIV, Bloomberg reports.

24 Jun 2008

FDA approves Kinrix - combination vaccine for diphtheria, tetanus, pertussis and polio diseases in one shot

GlaxoSmithKline has announced that the U.S. Food and Drug Administration (FDA) has approved Kinrix [Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine], the first combination vaccine to offer protection against diphtheria, tetanus, pertussis and polio diseases in one shot.

24 Jun 2008

Irritable bowel syndrome linked to chilli pepper pain receptor

People with irritable bowel syndrome have a higher than usual number of chilli pepper pain receptors, according to a new study published tomorrow (Wednesday 11 June).

10 Jun 2008

Boehringer, Gilead freeze antiretroviral prices for some U.S. agencies

Pharmaceutical companies Boehringer Ingelheim and Gilead Sciences are freezing the prices of their antiretroviral drugs for select agencies in the U.S., the AIDS Healthcare Foundation announced on Tuesday, Bloomberg reports.

8 Jun 2008

GlaxoSmithKline Acquires Sirtris Pharmaceuticals

GlaxoSmithKline has announced that it has completed its acquisition of Sirtris Pharmaceuticals, Inc. (Sirtris) for approximately USD720 million (or approx. GBP362 million) through a cash tender offer and merger of USD22.50 (or approx. GBP11.33) per share.

8 Jun 2008

Boehringer Ingelheim, Gilead to freeze AIDS drug price

AIDS Healthcare Foundation (AHF) today applauded decisions by Boehringer Ingelheim (BI) and Gilead Sciences, Inc. to freeze prices on antiretroviral medications purchased by government agencies.

3 Jun 2008

Quality of life predicts cancer survival

Head and neck cancer patients who reported lower physical quality of life were more likely to die from their disease, according to a new study from the University of Michigan Comprehensive Cancer Center. The findings could mean that identifying patients with poor quality of life could also identify patients with particularly aggressive tumors.

30 May 2008

Novel replacement for conventional needle and syringe

Chris Holden (21), A third year design student at Northumbria University, has won a prestigious national award for medical design by redesigning the conventional needle and syringe.

30 May 2008

Nurse-midwives present blankets for babies to Boston area women's organizations

Women, newborns, and families in the Boston area will benefit from the contributions of new and handmade blankets during the American College of Nurse-Midwives (ACNM) annual Blankets for Babies public service campaign during the ACNM 53rd Annual Meeting & Exhibit in Boston. Three area women's organizations will receive baby blankets, which are donated by certified nurse-midwives, certified midwives, student nurse-midwives, exhibitors and other meeting guests.

27 May 2008